Literature DB >> 9733892

Specific and independent recognition of U3 and U5 att sites by human immunodeficiency virus type 1 integrase in vivo.

T Masuda1, M J Kuroda, S Harada.   

Abstract

The retroviral attachment (att) sites at viral DNA ends are cis-acting regions essential for proviral integration. To investigate the sequence features of att important for human immunodeficiency virus type 1 (HIV-1) integration in vivo, we generated a series of 25 att mutants of HIV-1 by mutagenesis of the U3, U5, or both boundaries of att. Our results indicated that the terminal 11 or 12 bp of viral DNA are sufficient for specific recognition by HIV-1 integrase (IN) and suggested that IN might recognize each att site independently in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733892      PMCID: PMC110226     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Mapping domains of retroviral integrase responsible for viral DNA specificity and target site selection by analysis of chimeras between human immunodeficiency virus type 1 and visna virus integrases.

Authors:  M Katzman; M Sudol
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

2.  Solution structure of the DNA binding domain of HIV-1 integrase.

Authors:  P J Lodi; J A Ernst; J Kuszewski; A B Hickman; A Engelman; R Craigie; G M Clore; A M Gronenborn
Journal:  Biochemistry       Date:  1995-08-08       Impact factor: 3.162

3.  Sequences in the human immunodeficiency virus type 1 U3 region required for in vivo and in vitro integration.

Authors:  A S Reicin; G Kalpana; S Paik; S Marmon; S Goff
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

4.  Different roles of bases within the integration signal sequence of human immunodeficiency virus type 1 in vitro.

Authors:  T Yoshinaga; T Fujiwara
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

5.  Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA(3Lys) (template/primer).

Authors:  C Isel; C Ehresmann; G Keith; B Ehresmann; R Marquet
Journal:  J Mol Biol       Date:  1995-03-24       Impact factor: 5.469

6.  Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases.

Authors:  F Dyda; A B Hickman; T M Jenkins; A Engelman; R Craigie; D R Davies
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

7.  An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.

Authors:  E Vicenzi; D S Dimitrov; A Engelman; T S Migone; D F Purcell; J Leonard; G Englund; M A Martin
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Juxtaposition of two viral DNA ends in a bimolecular disintegration reaction mediated by multimers of human immunodeficiency virus type 1 or murine leukemia virus integrase.

Authors:  S A Chow; P O Brown
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1.

Authors:  G Englund; T S Theodore; E O Freed; A Engelman; M A Martin
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr.

Authors:  V Planelles; F Bachelerie; J B Jowett; A Haislip; Y Xie; P Banooni; T Masuda; I S Chen
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more
  41 in total

1.  Substrate sequence selection by retroviral integrase.

Authors:  H Zhou; G J Rainey; S K Wong; J M Coffin
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  DNase protection analysis of retrovirus integrase at the viral DNA ends for full-site integration in vitro.

Authors:  A Vora; D P Grandgenett
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Asymmetric processing of human immunodeficiency virus type 1 cDNA in vivo: implications for functional end coupling during the chemical steps of DNA transposition.

Authors:  H Chen; A Engelman
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

Review 4.  Integration-deficient lentiviral vectors: a slow coming of age.

Authors:  Klaus Wanisch; Rafael J Yáñez-Muñoz
Journal:  Mol Ther       Date:  2009-06-02       Impact factor: 11.454

Review 5.  Lentiviral vector-mediated RNA silencing in the central nervous system.

Authors:  Thomas H Hutson; Edmund Foster; Lawrence D F Moon; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther Methods       Date:  2013-11-01       Impact factor: 2.396

6.  Integration of rous sarcoma virus DNA: a CA dinucleotide is not required for integration of the U3 end of viral DNA.

Authors:  Jangsuk Oh; Kevin W Chang; Stephen H Hughes
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

7.  Transgene expression in the mouse cerebellar Purkinje cells with a minimal level of integration using long terminal repeat-modified lentiviral vectors.

Authors:  Kiyohiko Takayama; Takashi Torashima
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

8.  Nucleoprotein complex intermediates in HIV-1 integration.

Authors:  Min Li; Robert Craigie
Journal:  Methods       Date:  2009-02-20       Impact factor: 3.608

9.  Mutations in the U5 region adjacent to the primer binding site affect tRNA cleavage by human immunodeficiency virus type 1 reverse transcriptase in vivo.

Authors:  Jangsuk Oh; Mary Jane McWilliams; John G Julias; Stephen H Hughes
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

10.  Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate.

Authors:  Jangsuk Oh; Kevin W Chang; Rafal Wierzchoslawski; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.